Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease. 2022

Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
Department of Neurology, Helsinki University Hospital, and Clinicum, University of Helsinki, Helsinki, Finland.

The neurophysiological correlates of gastrointestinal symptoms (GISs) in Parkinson's disease (PD) are not well understood. It has been proposed that in patients with a gastrointestinal origin of PD dopaminergic neurodegeneration would be more symmetric. The aim is to assess the associations between GISs and asymmetry of nigrostriatal dopaminergic neurodegeneration in PD. Ninety PD patients were assessed using motor and GIS scales and 123 I-FP-CIT SPECT. We calculated the asymmetry index and the predominant side of motor symptoms and dopamine transporter (DAT) imaging defect and assessed their association with GISs. There were no significant differences in GISs between symmetric and asymmetric dopaminergic defect. Left predominant defect was related to more GIS and higher constipation scores. GISs were associated with left predominant reduction in putaminal DAT binding but not asymmetry per se. It remains open whether left-sided DAT deficit is related to more pronounced GI involvement or symptom perception in PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014326 Tropanes N-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in PLANTS. Azabicyclo(3.2.1)Octanes
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D050483 Dopamine Plasma Membrane Transport Proteins Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS. Dopamine Plasma Membrane Transporter Proteins,Neurotransmitter Transport Proteins, Dopamine-Specific,Neurotransmitter Transporters, Dopamine-Specific,DAT Dopamine Transporter,DAT Dopamine Transporter Proteins,Dopamine Carriers,Dopamine Transporter,Dopamine Transporter Proteins,Dopamine Uptake Complex,SLC6A3 Protein,Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein,Carriers, Dopamine,Dopamine Transporter, DAT,Dopamine-Specific Neurotransmitter Transporters,Neurotransmitter Transport Proteins, Dopamine Specific,Neurotransmitter Transporters, Dopamine Specific,Protein, SLC6A3,Transporter Proteins, Dopamine,Transporter, DAT Dopamine,Transporter, Dopamine,Transporters, Dopamine-Specific Neurotransmitter

Related Publications

Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
March 2020, Parkinsonism & related disorders,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
April 2018, Movement disorders : official journal of the Movement Disorder Society,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
June 2023, Clinical and translational science,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
October 2018, Parkinsonism & related disorders,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
February 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
March 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
June 2004, Annals of neurology,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
January 1991, Movement disorders : official journal of the Movement Disorder Society,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
September 2020, Clinical neurology and neurosurgery,
Kirsi Murtomäki, and Tuomas Mertsalmi, and Elina Jaakkola, and Elina Mäkinen, and Reeta Levo, and Tanja Nojonen, and Mikael Eklund, and Simo Nuuttila, and Kari Lindholm, and Eero Pekkonen, and Juho Joutsa, and Tommi Noponen, and Toni Ihalainen, and Valtteri Kaasinen, and Filip Scheperjans
November 2023, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!